Israel
With a global footprint, an established on-the-ground presence in Israel and strong relationships with local law firms, our team is well-positioned to represent Israeli companies of all sizes, along with investors looking to acquire or invest in Israeli companies. For years, we have ranked number one in volume of capital markets transactions in Israel, and you can rely on our experience and respected reputation for both inbound and outbound work in capital markets and securities, as well as M&A. We also collaborate with top-ranked colleagues across practices and offices worldwide—including our world-class healthcare practice, as the only law firm to be ranked #1 in healthcare by all the leading industry rankings—to handle any of your most pressing legal needs.
When you hire us, you gain access to a full-service global network of skilled lawyers spanning corporate and M&A, tax, healthcare and life sciences, private equity, litigation, employment and beyond. Many of our lawyers are native Hebrew speakers, and because we do not practice Israeli law, we have developed trusted, longstanding partnerships with local law firms. Our ability to navigate the local language and culture, along with Delaware law and complex securities laws both internationally and in the United States, gives you an edge in securing financing, completing transactions in and outside of Israel, establishing your company’s presence overseas and achieving your other business objectives.
- INX Limited, an Israel-based company seeking to launch trading platforms for cryptocurrencies and security tokens, in its initial public offering of up to 130 million INX Tokens at a purchase price of $0.90 per Token. This was the first public offering of blockchain assets registered under the Securities Act of 1933
- Galmed Pharmaceuticals Ltd., an Israeli biotech company, in a public offering of 5,000,000 ordinary shares of Galmed. The offering resulted in aggregate net proceeds of $70.5 million after underwriting discounts and commissions but before expenses
- CollPlant Holdings Ltd., a biotechnology medical device company, in its Nasdaq listing, multiple PIPE transactions and ongoing securities matters
- InterCure, the leading, profitable, and fastest growing cannabis company outside of North America, in its listing on Nasdaq
- Verbit, the world’s largest AI-powered transcription platform, as US counsel in its acquisition of VITAC, the largest provider of captioning products and solutions in North America
